Gefitinib-Induced Paronychia
Open Access
- 1 December 2012
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 148 (12), 1399-1402
- https://doi.org/10.1001/archdermatol.2012.3022
Abstract
Background Paronychia has been reported in as many as 10% of patients treated with gefitinib. Although conservative management and treatment with topical or systemic antibiotics are beneficial, no effective method exists for intractable cases. Platelet-rich plasma (PRP) consists of a high concentration of platelets that promote wound healing through chemotaxis, cell proliferation, angiogenesis, and tissue remodeling. Observations We herein report a refractory case of gefitinib-induced paronychia successfully treated with autologous PRP. A 68-year-old woman who had been diagnosed as having lung adenocarcinoma with multiple bone and brain metastases initiated gefitinib therapy at an oral dose of 250 mg/d. After 1 month, multiple paronychia with periungual granulation appeared on the nail fold of the first, second, and third toenails of both feet. Because the paronychia recurred repeatedly despite use of a topical antibiotic, topical corticosteroid, and short-term systemic antibiotic, she started PRP treatment. After 3 months, the lesion showed marked improvement with minimal pain or discharge. Conclusion This case highlights the therapeutic challenges of using PRP to promote tissue repair in intractable gefitinib-induced paronychia and merits further investigation.Keywords
This publication has 15 references indexed in Scilit:
- Rapid Healing and Reduced Erythema after Ablative Fractional Carbon Dioxide Laser Resurfacing Combined with the Application of Autologous Platelet-Rich PlasmaDermatologic Surgery, 2011
- The use of autologous PRP gel as an aid in the management of acute trauma woundsInjury, 2009
- Chemotherapeutic agents and the skin: An updateJournal of the American Academy of Dermatology, 2008
- The Healing Effects of Autologous Platelet Gel on Acute Human Skin WoundsArchives of Facial Plastic Surgery, 2007
- Platelet-Rich Plasma: A Review of Biology and Applications in Plastic SurgeryPlastic and Reconstructive Surgery, 2006
- Dermatologic side effects associated with the epidermal growth factor receptor inhibitorsJournal of the American Academy of Dermatology, 2006
- Platelet Quantification and Growth Factor Analysis from Platelet-Rich Plasma: Implications for Wound HealingPlastic and Reconstructive Surgery, 2004
- Cutaneous Side Effects in Non-Small Cell Lung Cancer Patients Treated with Iressa (ZD1839), an Inhibitor of Epidermal Growth FactorActa Dermato-Venereologica, 2003
- Development of Multiple Paronychia and Periungual Granulation in Patients Treated with Gefitinib, an Inhibitor of Epidermal Growth Factor ReceptorDermatology, 2003
- Paronychia Induced by Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorThe Journal of Dermatology, 2003